Systems medicine analysis of sarcoidosis by targeting mTOR in a co-clinical trial in patients and mice
Dauer: 48 Monate, Fördersumme: € 799.570
Protecting vascular barrier function across discipline and disease boundaries
Dauer: 54 Monate, Fördersumme: € 366.000
Deciphering genomic aberrations in rare skin cancers to find mechanism-based treatment strategies
Dauer: 82 Monate, Fördersumme: € 972.100